Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
D5gUKnULey8HfcsU